Scott Whitaker, president and CEO of AdvaMed, the world’s largest trade association representing medtech innovators, released the following statement after Fridays’ Supreme Court ruling on tariffs. Today, he published a more fulsome readout on LinkedIn, available here.
“Today’s ruling by the Supreme Court makes clear that IEEPA cannot be used to levy broad tariffs on markets around the world.
“With that said, we expect the administration will now pursue tariffs through other authorities to meet the President’s goal of eliminating trade imbalances and incentivizing U.S. manufacturing.
“As an industry that is primarily U.S.-based, with trade surpluses in most major markets worldwide, we look forward to working with the President and his administration to find a way to help reach his goals of leveling the playing field, addressing foreign trade barriers, and ensuring that the U.S. continues to lead the world in medical innovation and patient care.
“As we move forward, it is essential that America’s medtech companies have the certainty and stability we need to invest, innovate and supply U.S. patients with the timely, cost-effective medical technologies they need.”
###
Call to Action Heading…
Call to Action Description…